Compare key investment metrics of 유유제약 and 체시스 in real time. Both stocks belong to the 김무성 관련주 sector. View PER (Price-to-Earnings Ratio), PBR (Price-to-Book Ratio), dividend yield, market capitalization, and 52-week high/low side by side, with automatic highlighting of the leading stock for each metric.
Comparison at a Glance
- On earnings-based valuation, 체시스 trades at a lower PER — 3.69x vs 유유제약's 8.24x. A lower PER can suggest undervaluation, but differences in growth expectations should also be considered.
- By market capitalization, 유유제약 is larger — ₩60B vs 체시스's ₩23B. Larger companies tend to be less volatile, while smaller ones may offer more growth headroom.
- 유유제약's current price of 3,800원 sits at about 15% of its 52-week range (3,575원–5,100원).
- 체시스's current price of 3,510원 sits at about 16% of its 52-week range (2,965원–6,385원).
- This comparison is for reference only, based on publicly available market data, and does not constitute investment advice.
| Metric | 유유제약 | 체시스 |
|---|---|---|
| Price | 3,800원 | 3,510원 |
| PER | 8.24배 | 3.69배 |
| PBR | 0.53배 | 0.47배 |
| Dividend Yield | 3.03% | - |
| Market Cap | ₩60B | ₩23B |
| 52-Week High | 5,100원 | 6,385원 |
| 52-Week Low | 3,575원 | 2,965원 |
As of 2026-07-06 · Source: KRX (Naver Finance) public data
Frequently Asked Questions
Which has a lower PER, 유유제약 or 체시스?
As of 2026-07-06, 체시스 has the lower PER — about 3.69x vs 유유제약's 8.24x. PER (Price-to-Earnings Ratio) divides a stock's price by its earnings per share; a lower PER may suggest undervaluation, but growth expectations should also be considered.
What is the dividend yield difference between 유유제약 and 체시스?
Dividend yield measures annual dividends as a percentage of the stock price. A higher yield means more cash income per dollar invested. The dividend yields of 유유제약 and 체시스 fluctuate with dividend policy changes and stock price movements — check this page's live data for the most current comparison.
How to compare 유유제약 and 체시스?
PFlow's stock comparison page lets you compare key investment metrics side by side — PER, PBR, dividend yield, market cap, and 52-week high/low. Each metric automatically highlights which stock has the advantage. For deeper analysis, visit each stock's dedicated detail page.